QuickStrip
Share
02/23/2026
Rapid Dose Therapeutics advances cannabinoid research and clinical evaluation of its proprietary QuickStrip™ oral thin film delivery platform. Independent studies, supported by grant funding, are exploring cannabinoids’ role in pain management and neuroprotection related to concussion and participation in contact sports, while a clinical arm is assessing CBD bioavailability vs traditional oral formats.
https://www.newsfilecorp.com/release/284877
$DOSE $RDTCF
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform Burlington, Ontario--(Newsfile Corp. - February 23, 2026) - Rapid Dose Therapeutics Corp. ...
A new CEO.ca interview featuring Rapid Dose Therapeutics CEO Mark Upsdell (CSE: DOSE).
He discusses NicStrip™, RDT’s ni****ne oral thin-film format, current development activity, ongoing regulatory submissions, and the QuickStrip™ platform.
11/11/2024
Today on this Remembrance Day, we commemorate and honor the courage, sacrifice, and resilience of those who have served and continue to serve.
Lest we forget.
Click here to claim your Sponsored Listing.
Category
Telephone
Website
Address
1121 Walker's Line, Unit 3A
Burlington, ON
L7N2G4
Opening Hours
| Monday | 9am - 5pm |
| Tuesday | 9am - 5pm |
| Wednesday | 9am - 5pm |
| Thursday | 9am - 5pm |
| Friday | 9am - 5pm |
